Results 181 to 190 of about 279,339 (314)

Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment

Advanced Science, EarlyView.
KRAS mutations dynamically remodel the tumor microenvironment (TME), fostering immunosuppression, metabolic symbiosis, and stromal plasticity. This review dissects how oncogenic KRAS variants sculpt TME networks and explores actionable vulnerabilities. Emerging strategies combining KRAS inhibitors and TME‐editing approaches offer potential to dismantle
Jiayao Ma, Shenao Fu, Jun Tan, Ying Han, Yihong Chen, Xiangying Deng, Hong Shen, Shan Zeng, Yinghui Peng, Changjing Cai   +9 more
wiley   +1 more source

PTX3 as a diagnostic and prognostic biomarker in lung adenocarcinoma: a comprehensive analysis. [PDF]

Discov Oncol
Zhou S, Li N, Haishaer D, Zhao H.
europepmc   +1 more source

Useful Prognostic Panel Markers to Express the Biological Tumor Status in Resected Lung Adenocarcinomas [PDF]

, 2000
Paulo Eduardo de Oliveira Carvalho
openalex   +1 more source

Adenocarcinoma of the lung

, 2017
openaire   +1 more source

Single‐Cell RNA Sequencing Identifies MMP11+ Cancer‐Associated Fibroblasts as Drivers of Angiogenesis and Bladder Cancer Progression

Advanced Science, EarlyView.
Single‐cell RNA sequencing identifies MMP11⁺ CAFs as pro‐angiogenic cells accumulating during bladder cancer progression. These cells promote angiogenesis by regulating ESM1⁺ tip endothelial cells and recruiting SPP1⁺ macrophages. Tumor‐derived BMP2 promotes their activation.
Wuwu Xu, Ting Liang, Hu Fang, Lu Fu, Dashi Deng, Xiyang Tan, Lisha Liu, Dongdong Tang, Haoxiang Zheng, Qiuxia Ding, Xiuqi Hou, Daquan Feng, Tao Tao, Song Wu   +13 more
wiley   +1 more source

Identification of PECAM1 as a Prognostic Biomarker for Lung Adenocarcinoma. [PDF]

Diagnostics (Basel)
Lin SS, Hsu PS, Lin YC, You JY, Shih YL, Lai HC.   +5 more
europepmc   +1 more source

Activity of growth factors in the IL-6 group in the differentiation of human lung adenocarcinoma [PDF]

, 2000
Carol McCormick, R. Ian Freshney
openalex   +1 more source

HLA‐DR⁺ Tumor Cells Show an Association with a Distinct Immune Microenvironment and CD8⁺ T‐Cell Exhaustion in HBV‐Associated Hepatocellular Carcinoma

Advanced Science, EarlyView.
This study integrates scRNA‐seq, multiplex immunofluorescence, and clinical data to identify HLA‐DR⁺tumor cells uniquely enriched in Hepatocellular carcinoma (HCC) with hepatitis B virus (HBV). These cells express MHC II, associate with PD‐L1, recruit and exhaust CD8⁺T cells, predict poor survival, and serve as potential biomarkers for immunotherapy ...
Jun‐Qing Chang, Yan Guo, Wen‐Jing Yuan, Yu‐Man Chen, Bo‐Wei Liu, Wen‐Tao Li, Xiang‐Ming Ding, Xu‐Dong Fu, Yu‐Han Lou, Zhuo‐Ran Chen, Xiao‐Ying Luo, Song‐Ze Ding, Bing‐Yong Zhang, Xiu‐Ling Li, Yong‐Zhi Hong, Shun‐Dong Cang, Dong‐Xiao Li, Ling Lan   +17 more
wiley   +1 more source

A Fragmented Rib as the First Clue to Advanced Lung Adenocarcinoma. [PDF]

Respirol Case Rep
Ishii H, Utsunomiya T, Kinoshita Y, Kushima H.   +3 more
europepmc   +1 more source

Venous Gangrene in a Patient with Adenocarcinoma of the Lung [PDF]

, 2000
Mu Yang
openalex   +1 more source